Pomalidomide

Category: Cancer



Pomalidomide Overview

Pomalidomide (INN; marketed as Pomalyst in the U.S.[2] and Imnovid in the EU and Russia) is a derivative of thalidomide marketed by Celgene. It is anti-angiogenic and also acts as an immunomodulator. Pomalidomide was approved in February 2013 by the U.S. Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma. It has been approved for use in people who have received at least two prior therapies including lenalidomide and bortezomib and h...

Read more Pomalidomide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pomalidomide

Recent Pomalidomide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pomalidomide
  • Capsule: 1mg, 2mg, 3mg, 4mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Pomalidomide or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 18 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA